Amit Rakhit's most recent trade in Ovid Therapeutics Inc was a trade of 34,017 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 14, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Amit Rakhit | President and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2021 | 34,017 | 90,983 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Amit Rakhit | President and CMO | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 14 Jul 2021 | 34,017 | 726,823 (1%) | 0% | 3.7 | 126,203 | Common Stock |
| Ovid Therapeutics Inc | Amit Rakhit | President and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 14 Jul 2021 | 34,017 | 760,840 (1%) | 0% | 1.9 | 64,292 | Common Stock |
| Ovid Therapeutics Inc | Amit Rakhit | President and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |